
What is acute myocardial infarction? Ozzy Osbourne's cause of death explained
It was one of three things listed on the 76-year-old Black Sabbath rocker's death certificate, which was released yesterday afternoon.
The document cited out of hospital cardiac arrest, acute myocardial infarction and coronary artery disease, and Parkinson's disease with autonomic dysfunction as the dad-of-five's cause of death.
An acute myocardial infarction is a medical term for a heart attack, and in Mr Osbourne's case it was connected to coronary artery disease.
Coronary artery disease is when fatty deposits (plaques) build up in the arteries.
This substance can narrow the arteries—a process called atherosclerosis—which reduces blood flow and increases the risks of heart attacks.
Furthermore, chunks of this plaque, which is made predominantly of cholesterol and other fat cells, can break off and cause obstructions, which can also trigger a heart attack if it affects the blood's movement through the body.
Out of hospital cardiac arrest refers to falling ill outside of hospital—in Mr Osbourne's case he became unwell while at home—and according to the British Heart Foundation, this is a medical emergency which fewer than 1 in 10 people survive.
Mr Osbourne was diagnosed with Parkinson's disease in 2019, and autonomic dysfunction refers to bodily functions which are affected by the condition.
The British Heart Foundation claims that in the UK, coronary heart disease—which includes heart attacks—is the cause of 66,000 deaths each year.
This translates to roughly 180 deaths per day, or one death every eight minutes.
In England and Wales alone, over 55,000 deaths were attributed to coronary artery disease—also referred to as ischemic heart disease—in 2019.
While Parkinson's Disease itself doesn't kill, studies have linked it to an increased risk of cardiovascular disease—including coronary artery disease.
This is because Parkinson's affects people's ability to walk and move around, making it near impossible for them to maintain a basic level of fitness, which keeps the vascular system healthy and functioning.
His passing came just weeks after he appeared on stage for his farewell concert at Villa Park stadium in his native Birmingham.
Due to Parkinson's-related mobility issues, he performed while seated on a giant black throne.
The concert, three weeks before his death, saw him reunite with his original Black Sabbath bandmates for the first time since 2005.
More than 42,000 fans packed into the venue for the Back To The Beginning show, during which he told the crowd in his final speech: 'You've no idea how I feel - thank you from the bottom of my heart.'
There were more than 5 million sign-ups to the concert's livestream, too.
The concert raised £140 million for charities close to Mr Osbourne's heart, Cure Parkinson's, Birmingham Children's Hospital and Acorn Children's Hospice.
In a statement shared last month, Ozzy's family said he died 'surrounded by love', adding: 'It is with more sadness than mere words can convey that we have to report that our beloved Ozzy Osbourne has passed away this morning.'
Mr Osbourne passed away on July 22 surrounded by his family at his Buckinghamshire Estate, where he was subsequently laid to rest last week.
The private funeral was attended by his family and a host of rock royalty.
His widow Sharon, 72, and their children, Aimee, Kelly and Jack, were joined by stars including Marilyn Manson and Ozzy's lead guitarist Zakk Wylde during the event at the family's 250-acre estate.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
3 minutes ago
- The Independent
Warning over ‘life-threatening' fake Ozempic jabs sold by bogus online pharmacies
Warnings have been issued over fake weight loss jabs that could be 'life-threatening' after thousands of fraudulent online pharmacies were uncovered. Fake versions of Ozempic, a popular brand of weight loss jab, were being sold for as little as £13.70 per dose, along with counterfeit versions of other brands, including Rybelsus and Metformin pills, being offered from 24p. The UK's medicines regulator said taking bogus medications could not only make people ill, but in some cases could be fatal. Researchers from cybersecurity company Gen, who conducted the research, warned of the 'dangerous' threat of the global scam involving more than 5,000 fake pharmacy sites this year, which they say are being run by criminal networks. It comes amid the rapid rise of weight-loss medication in the UK - with around 1.5 million people, 4 per cent of households, currently using them. Gen also found fake Viagra, a medicine used to treat erection issues, and unregulated fertility pills being sold. The company said lab tests found no active ingredient in a third of the drugs tested. Andy Morling, deputy director of criminal enforcement at the Medicines and Healthcare products Regulatory Agency (MHRA), told The Independent: 'Buying medicines from illegal suppliers significantly increases the risk of receiving products that are either falsified or not licensed for use in the UK. Products purchased in this way will not meet the MHRA's strict quality and safety standards, and taking such medicines may put one's health at risk.' 'Fake prescription and over-the-counter medicines not only fail to work but can also make you sick. Even worse, in the most severe cases, they may contain dangerous ingredients, potentially leading to death,' the regulator added. The researchers warned that the 'alarmingly' polished websites, complete with bogus customer service information, detailed product pages, and looked similar to legitimate online pharmacies. But many were detected as fakes because they used AI to create reviews, health blogs, live chat support and manipulated search results. As well as the health implications, the researchers said UK customers risked their details and identity being stolen by the sites. Siggi Stefnission, cyber safety chief technology officer at Gen, warned: 'Purchasing pharmaceuticals from untrusted online retailers is a serious danger, both to individual health and to someone's digital safety. 'From a public health perspective, counterfeit or unregulated drugs can be ineffective or even life-threatening. It's critical that consumers only use licensed, reputable online pharmacies to protect themselves from cybercrime and potential physical harm.' The popularity of weight-loss jabs has soared in the past year, with the NHS 's top doctor, Sir Stephen Powis, saying they could soon become among the most commonly used drugs. Both Ozempic and Rybelsus, which have the active ingredient semaglutide, are not licensed as a weight loss treatment. Instead they are designed to treat people with type 2 diabetes but both are sometimes prescribed off-label to treat weight loss. However, popular weight loss jabs Wegovy, which has the same active ingredient, and Mounjaro, which uses the active ingredient tirzepatide, are both licensed in the UK for the treatment of weight loss. Gen explained that criminals are taking advantage of people looking for a fast and discreet way to get high-demand weight loss treatment, among other medications that are often sought quickly, privately, or at a lower cost. Alongside the vast network of more than 5,000 web domains selling the in-demand drugs fraudulently, Gen said, this year alone, it has already blocked 1 million attacks coming from these sites against unsuspecting online shoppers. Laura Wilson, director at Royal Pharmaceutical Society, said fake and illegal online pharmacies 'are a growing threat to patient safety'. She explained that fraudulent medicines may be out of date, substandard or contain 'dangerous' substances. Gen said its team is currently working on testing fake medications to work out what exactly they are made of. The company advised consumers to watch out for low-cost offers for prescription-only drugs, missing contact information, requests for cryptocurrency payments, unsecured checkout processes, and prompts for sensitive personal, medical, or financial data. Novo Nordisk, the company that makes Ozempic and Rybelsus, said it was aware that counterfeit Ozempic products are being sold in the UK and is working with health authorities, including the MHRA, to investigate the 'critical issue'. It advised people to examine packaging and pens closely before using them. Mr Morling said the MHRA is cracking down on the issue of fake medicines and pharmacies, with offenders potentially facing criminal investigation and prosecution.


BBC News
34 minutes ago
- BBC News
Innovative device at Royal Surrey improves prostate cancer result
A hospital in Surrey says it is the first NHS trust in the UK to use a "revolutionary" new device that improves prostate cancer surgery and reduces the need for Histolog Scanner allows surgeons at Royal Surrey County Hospital to assess the prostate for cancerous tissue in real-time during surgery rather than wait for post-operation trust says the technology enables surgeons to remove additional tissue if required, potentially reducing the risk of leaving behind cancerous cells. Wissam Abou-Chedid, consultant urological surgeon, said: "This technology marks a real leap forward in prostate cancer surgery." He said: "For the first time, we can assess tissue in real time while the patient is still on the operating table – allowing us to make immediate, informed decisions that improve cancer control without putting quality of life at risk."It means fewer patients needing radiotherapy afterwards, and more men retaining their continence and sexual function."Royal Surrey's urology clinical director, Dimitrios Moschonas, said the scanner strengthens the hospital's reputation as a national leader in prostate cancer treatment and robotic surgery."As the highest-volume single-site centre for robotic prostatectomy in the UK, Royal Surrey continues to lead with pioneering initiatives," he said. In May 2023, Royal Surrey's urology team set a record, performing 12 robotic prostatectomies in a single day. In August, the team was shortlisted for an HSJ award for its catheter scheme to assist prostate cancer patients following robotic surgery. Patients are taught how to safely remove their own catheters at home, avoiding return trips to the hospital.


The Guardian
2 hours ago
- The Guardian
Eli Lilly ramps up UK price of weight loss jab Mounjaro after Trump demands
The price of the weight loss jab Mounjaro will rise by up to 170% in the UK, its US manufacturer has said, as Donald Trump ramps up pressure on drugmakers to increase their prices for Europeans so that they can make them more affordable for Americans. Eli Lilly has said it will increase the price of the drug from September, with a month's supply of the highest dose rising from £122 to £330. Mounjaro contains tirzepatide and is self-administered in once-a-week injections. When it launched in Britain in February 2024, Eli Lilly agreed to a list price 'significantly below' its other European markets to stop delays in availability of the medicine through the NHS. The increase in the list price will align it 'more consistently', the company said, although it added the NHS would not pay the new higher price to ensure continued access for the people with obesity and type 2 diabetes receiving it through the health service. Eli Lilly said it was working with private healthcare providers, which could negotiate their own confidential discounts with the company. Trump has threatened to use 'every tool in our arsenal' to crack down on pharmaceutical companies charging higher prices in the US compared with other nations. The US pays about three times more for drugs compared with other developed countries, according to the Rand Corporation thinktank. On 31 July, Trump sent letters to 17 of the world's biggest drugmakers, including Eli Lilly and Novo Nordisk, demanding cuts to drug prices for Americans within 60 days. 'Make no mistake: a collaborative effort towards achieving global pricing parity would be the most effective path for companies, the government and American patients,' Trump wrote. 'But if you refuse to step up we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices. 'Americans are demanding lower drug prices, and they need them today.' In May, Trump told reporters that a friend in London had told him he had bought the 'fat shot drug' for $88, compared with $1,300 in New York. Pharmaceutical companies have cashed in on huge demand for weight loss treatments. Denmark's Novo Nordisk has become one of the most prominent names in the field, launching Wegovy in the UK in September 2023, turning it into one of the most valuable companies in Europe. While the jabs have increased profits at big pharmaceutical companies, they are racing to develop an equivalent pill, which would be a more convenient and cheaper alternative for patients and healthcare authorities. Eli Lilly said this month that a pill in early trial stages showed that participants on their highest dose lost an average of 12.4% of their body weight, compared with 0.9% of the control group. Novo Nordisk has submitted its oral weight loss drug for approval in the US. Its trial results showed that participants could lose about 15% of their body weight.